{'fraction_non_alphanumeric': 0.04865334491746308, 'fraction_numerical': 0.02519548218940052, 'mean_word_length': 5.160427807486631, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A new method for one-step, no-carrier-added synthesis of cholesteryl 4-[18F]-fluorobenzoate ([18F]-CFB), a radiotracer used in detection of adrenal malignancies.

PURPOSE
Cholesteryl 4-[(18)F]-fluorobenzoate, a potential radiotracer used for adrenal and ovarian imaging, was prepared in no-carrier-added form from cholesteryl 4-N,N,N-trimethylanilinium trifluoromethanesulfonate.


METHODS
The reaction was performed in one step using Kryptofix2.2.2/[(18)F], carbonate as the counter ion and dimethyl sulfoxide as the solvent at 110 degrees C. Purification was performed using commercially available C(18) and Si Sep-Paks.


RESULTS
Column purification afforded the desired compound in 75-85 % radiochemical yield (EOS) with a specific activity about 74 KBq/mmole in about 20 minutes, with greater than 95% radiochemical and chemical purity (HPLC and TLC analysis).


CONCLUSIONS
This compound was prepared through a novel method which can be easily performed at distant locations from the main radionuclide production centers using Sep-Paks. The biodistribution of this compound in mice was confirmed to be similar to that reported in the literature.